Download PDF
1 / Pages

Other users also viewed these articles

Cost-effectiveness of omalizumab in real world uncontrolled allergic asthma patients A. Arrobas; M.P. Barbosa; S. Rabiais; B. Vandewalle; J. Félix;
Pulmonol. 2021;27:124-33
Delays have dangerous ends: Tuberculosis diagnosis delay in Portugal, a qualitative study T. Silva; A. Aguiar; A. Gomes; M. Marques; C. Pereira; R. Rodrigues; M. Pinto; R. Duarte;
Pulmonol. 2024;30:653-8
Chronic obstructive pulmonary disease exacerbations' management in Portuguese hospitals ¿ EvaluateCOPDpt, a multicentre, observational, prospective study J. Moita; U. Brito; C. Rodrigues; L. Ferreira; J.R. Vieira; A. Catarino; A. Morais; V. Hespanhol; C.R. Cordeiro;
Pulmonol. 2024;30:522-8